Sign inJoin waitlistJoin the waitlist

Atsushi Sakuraba

Associate Professor, Department of Internal Medicine · Rush University Medical Center

Credentials: · · · ·

History

Rush University Medical Center
Present

Gastroenterology
2015–2018
Internal Medicine
2012–2015
Keio University School of Medicine
1993–1997

Research

Unique CD14 intestinal macrophages contribute to the pathogenesis of Crohn disease via IL-23/IFN-gamma axis
Journal of Clinical Investigation · 2008 · 540 citations
Prevalence and clinical outcomes of COVID-19 in patients with autoimmune diseases: a systematic review and meta-analysis
Systematic review or meta-analysis · Annals of the Rheumatic Diseases · 2021 · Last of 4 authors · Corresponding · 299 citations
Imbalance in intestinal microflora constitution could be involved in the pathogenesis of inflammatory bowel disease
International Journal of Medical Microbiology · 2008 · 251 citations

David Rubin
45 papers
Dejan Micic
45 papers · 13 as a fellow
Russell Cohen
42 papers
Joel Pekow
39 papers
Sushila Dalal
35 papers
JO
Jacob Ollech
16 papers · 15 as a resident
SA
Shintaro Akiyama
16 papers · 16 as a resident
NH
Neil Hyman
14 papers
Roger Hurst
13 papers
Konstantin Umanskiy
12 papers
Benjamin Shogan
9 papers
LG
Laura Glick
9 papers · 6 as a resident

Clinical trials

A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease
Site PI · Recruiting · Phase 2
Eli Lilly and Company
2026–2028
A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
Site PI · Recruiting · Phase 2
Eli Lilly and Company
2026–2028
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Site PI · Recruiting · Phase 2
Eli Lilly and Company
2026–2031
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
Site PI · Recruiting · Phase 3
Eli Lilly and Company
2025–2028